JUM etoc signup
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Youk, J. H.
Right arrow Articles by Lee, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Youk, J. H.
Right arrow Articles by Lee, J. M.
© 2003 by the American Institute of Ultrasound in Medicine
J Ultrasound Med 22:897-910 • 0278-4297

Contrast-Enhanced Agent Detection Imaging

Value in the Characterization of Focal Hepatic Lesions

Ji Hyun Youk, MD, Chong Soo Kim, MD and Jeong Min Lee, MD

Department of Radiology, Chonbuk National University Hospital, Jeonju, South Korea (J.H.Y., C.S.K.); and Department of Radiology, Seoul National University College of Medicine, Seoul, South Korea (J.M.L.).

Address correspondence and reprint requests to Jeong Min Lee, MD, Department of Radiology, Seoul National University Hospital, 28 Yongon-dong, Chongno-gu, Seoul 110-744, South Korea. E-mail: leejm{at}radcom.snu.ac.kr.

Objective. To assess the value of SH U 508A-enhanced agent detection imaging in the characterization of focal hepatic lesions. Methods. Contrast-enhanced agent detection imaging was performed on 78 focal hepatic lesions: 34 hepatocellular carcinomas, 22 metastases, 9 hemangiomas, 9 abscesses, 3 cysts, and 1 focal nodular hyperplasia. After administration of SH U 508A, interval delay scanning with agent detection imaging was performed with intervals of approximately 7 seconds (phase I), 30 seconds (phase II), and 90 seconds (phase III) after the first arrival of the contrast agent to the liver. Two observers blinded to the final diagnosis reviewed selected images and assessed the enhancement patterns of the lesions. For quantitative analysis, we calculated the enhancement ratio of the lesions and the difference of enhancement between the lesions and the liver parenchyma. Results. Agent detection imaging showed a distinctive enhancement pattern in focal liver lesions compared with that in the liver. Hepatocellular carcinomas were characterized by early enhancement (phase I) and wash-out (phases II and III; sensitivity, 94.1%; specificity, 93.2%; positive predictive value, 91.4%). Metastases showed peripheral rim or targetlike enhancement (phase I, phase II, or both) and a defect (phase III) and had sensitivity of 77.3%, specificity of 100%, and a positive predictive value of 100%. Hemangiomas showed peripheral nodular or inhomogeneous (phase I, phase II, or both) and gradually centripetal (phase II, phase III, or both) enhancement (sensitivity, 88.9%; specificity, 100%; positive predictive value, 100%). Abscesses were partially enhanced from phase I to phase III (sensitivity, 66.7%; specificity, 95%; positive predictive value, 85.7%). The results of the quantitative analysis of lesion enhancement were compatible with those of the qualitative analysis. Conclusions. SH U 508A-enhanced agent detection imaging may yield distinctive enhancement characteristics in focal liver lesions that would contribute positively to the characterization of these hepatic lesions.

Key Words: agent detection imaging • contrast media • liver • tumors • ultrasonography

Abbreviations: ADI, agent detection imaging • ANOVA, analysis of variance • CT, computed tomography • FNH, focal nodular hyperplasia • HCC, hepatocellular carcinoma • LLE, lesion-to-liver enhancement • MI, mechanical index • MR, magnetic resonance • PIHI, phase inversion harmonic imaging • PPV, positive predictive value • SI, signal intensity




This article has been cited by other articles:


Home page
J Ultrasound MedHome page
G.-J. Liu, M.-D. Lu, X.-Y. Xie, H.-X. Xu, Z.-F. Xu, Y.-L. Zheng, J.-Y. Liang, and W. Wang
Real-time Contrast-Enhanced Ultrasound Imaging of Infected Focal Liver Lesions
J. Ultrasound Med., April 1, 2008; 27(4): 657 - 666.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
O. Catalano, V. Migaleddu, E. Quaia, and G. Caruso
Terminology for Contrast-Enhanced Sonography: A Practical Glossary
J. Ultrasound Med., June 1, 2007; 26(6): 717 - 730.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. H. Kim, J. M. Lee, J. Y. Lee, J. K. Han, S. K. An, C. J. Han, K. H. Lee, S. S. Hwang, and B. I. Choi
Value of Contrast-Enhanced Sonography for the Characterization of Focal Hepatic Lesions in Patients with Diffuse Liver Disease: Receiver Operating Characteristic Analysis
Am. J. Roentgenol., April 1, 2005; 184(4): 1077 - 1084.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
O. Catalano, A. Nunziata, R. Lobianco, and A. Siani
Real-Time Harmonic Contrast Material-specific US of Focal Liver Lesions
RadioGraphics, March 1, 2005; 25(2): 333 - 349.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Institute of Ultrasound in Medicine.